Marriage Counselors in Watertown, MA Accepting Medicare

2 Marriage Counselors found. Showing 1 - 2

Erin Kim, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 32 Whites Ave Apt D33, Watertown, MA 02472 Phone: 781-860-2325

Alyson Bullock, AMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 71 Carroll St, Watertown, MA 02472 Phone: 858-349-0300

News Archive

Researchers use American College of Cardiology registry to improve cardiovascular care delivery in India

Despite challenges, it is feasible to collect and study the quality of outpatient cardiovascular care in a resource-limited environment like India, according to a pilot study published today in the Journal of the American Heart Association.

Nuclear Regulatory Commission licenses Positron facility in Fishers to handle radioactive material

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced today that the Nuclear Regulatory Commission has licensed the Positron facility in Fishers, Indiana to handle radioactive material.

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

A recent paper in the journal Nature shows that while earlier lineages do not elicit antibodies capable of efficiently neutralizing the newly emerged South African variant, SARS-CoV-2 501Y.V2 (B.1.351), the converse does occur.

Researchers discuss potential benefits of Chinese plants and their therapeutic efficacy

Announcing a new article publication for BIO Integration journal. In this review article the authors Xiuling Li, Shunung Liang, Chee Hwee Tan, Shuwen Cao, Xiaoding Xu, Phei Er Saw and Wei Tao from Sun Yat-sen University, Guangzhou, China, Guangzhou University of Chinese Medicine, Guangzhou, China and Center for Harvard Medical School, Boston, MA, USA discuss the potential benefits of four plants endogenous to China and the enhancement of their therapeutic efficacy by nanotechnology intervention.

Gilead to amend design of ongoing clinical trials against chronic hepatitis C

Gilead Sciences, Inc. today announced that, in consultation with the U.S. Food and Drug Administration (FDA), the company will amend the design of ongoing clinical trials to discontinue dosing of GS 9190 in hepatitis C-infected patients who are receiving that compound in combination with pegylated interferon and ribavirin, and another direct-acting antiviral agent.

Read more Medical News

› Verified 4 days ago